References
- Proano RA, Jacobson SH, Zhang W. Making combination vaccines more accessible to low-income countries: the antigen bundle pricing problem. Omega 40(1), 53–64 (2012).
- Hecht R, Kaddar M, Schmitt S. Transparent pricing of vaccines would help poor as well as rich countries. BMJ 343, d7414 (2011).
- Lee BY, McGlone SM. Pricing of new vaccines. Hum. Vaccin. 6(8), 619–626 (2010).
- Robbins MJ, Jacobson SH, Sewell EC. Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel? Health Care Manag. Sci. 13(1), 54–64 (2010).
- Robbins MJ, Jacobson SH, Shanhbag UV. The weighted set covering game: a vaccine pricing model for pediatric immunization. Technical Report, University of Illinois, IL, USA (2012).
- Zuber PL, El-Ziq I, Kaddar M et al. Sustaining GAVI-supported vaccine introductions in resource-poor countries. Vaccine 29(17), 3149–3154 (2011).
- Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff. (Millwood) 30(6), 1113–1121 (2011).
- Ehreth J. The global value of vaccination. Vaccine 21(7–8), 596–600 (2003).
- Robbins MJ, Jacobson SH. The altruistic monopsonist vaccine formulary pricing and purchasing problem: informing public health policy. Omega 39(6), 589–597 (2011).
- Field RI, Caplan AL. Evidence-based decision making for vaccines: the need for an ethical foundation. Vaccine 30(6), 1009–1013 (2012).
- Shrestha SS, Wallace GS, Meltzer MI. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences. Vaccine 28(38), 6318–6332 (2010).